Literature DB >> 2154852

Molecular characterization of a functional cDNA encoding the rat substance P receptor.

A D Hershey1, J E Krause.   

Abstract

Substance P is a member of the tachykinin peptide family and participates in the regulation of diverse biological processes. The polymerase chain reaction and conventional library screening were used to isolate a complementary DNA (cDNA) encoding the rat substance P receptor from brain and submandibular gland. By homology analysis, this receptor belongs to the G protein-coupled receptor superfamily. The receptor cDNA was expressed in a mammalian cell line and the ligand binding properties of the encoded receptor were pharmacologically defined by Scatchard analysis and tachykinin peptide displacement as those of a substance P receptor. The distribution of the messenger RNA for this receptor is highest in urinary bladder, submandibular gland, striatum, and spinal cord, which is consistent with the known distribution of substance P receptor binding sites. Thus, this receptor appears to mediate the primary actions of substance P in various brain regions and peripheral tissues.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2154852     DOI: 10.1126/science.2154852

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  36 in total

Review 1.  In vitro mutagenesis and the search for structure-function relationships among G protein-coupled receptors.

Authors:  T M Savarese; C M Fraser
Journal:  Biochem J       Date:  1992-04-01       Impact factor: 3.857

2.  A substance P (neurokinin-1) receptor mutant carboxyl-terminally truncated to resemble a naturally occurring receptor isoform displays enhanced responsiveness and resistance to desensitization.

Authors:  H Li; S E Leeman; B E Slack; G Hauser; W S Saltsman; J E Krause; J K Blusztajn; N D Boyd
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

3.  PKCɛ mediates substance P inhibition of GABAA receptors-mediated current in rat dorsal root ganglion.

Authors:  Li Li; Lei Zhao; Yang Wang; Ke-Tao Ma; Wen-Yan Shi; Ying-Zi Wang; Jun-Qiang Si
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2015-02-12

4.  Human NK-2 receptor gene maps to chromosome region 10q11-21.

Authors:  J E Morten; B Hopkins; S J Powell; A Graham
Journal:  Hum Genet       Date:  1991-12       Impact factor: 4.132

5.  Further evidence for the existence of NK2 tachykinin receptor subtypes.

Authors:  R Patacchini; M Astolfi; L Quartara; P Rovero; A Giachetti; C A Maggi
Journal:  Br J Pharmacol       Date:  1991-09       Impact factor: 8.739

6.  Substance P-induced inflammatory responses in guinea-pig skin: the effect of specific NK1 receptor antagonists and the role of endogenous mediators.

Authors:  D T Walsh; V B Weg; T J Williams; S Nourshargh
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

7.  Characterization of a tachykinin peptide NK2 receptor transfected into murine fibroblast B82 cells.

Authors:  P L van Giersbergen; S A Shatzer; A K Henderson; J Lai; S Nakanishi; H I Yamamura; S H Buck
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-01       Impact factor: 11.205

8.  A combined evaluation of biochemical and morphological changes during human neuroblastoma cell differentiation.

Authors:  M Lanciotti; P G Montaldo; S Folghera; E Lucarelli; P Cornaglia-Ferraris; M Ponzoni
Journal:  Cell Mol Neurobiol       Date:  1992-06       Impact factor: 5.046

9.  Characterization of antisera specific to NK1, NK2, and NK3 neurokinin receptors and their utilization to localize receptors in the rat gastrointestinal tract.

Authors:  E F Grady; P Baluk; S Böhm; P D Gamp; H Wong; D G Payan; J Ansel; A L Portbury; J B Furness; D M McDonald; N W Bunnett
Journal:  J Neurosci       Date:  1996-11-01       Impact factor: 6.167

10.  An isobolographic analysis of the effects of N-methyl-D-aspartate and NK1 tachykinin receptor antagonists on inflammatory hyperalgesia in the rat.

Authors:  K Ren; M J Iadarola; R Dubner
Journal:  Br J Pharmacol       Date:  1996-01       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.